Tag: Nrti

First approved by the FDA in 1998, the antiretroviral medication abacavir has been a key component in HIV treatment. It is important for patients to know what is the generic name of abacavir, which is simply abacavir, and understand its primary brand name, Ziagen, as well as its availability in combined formulations.

Drug-induced acute pancreatitis accounts for 0.1% to 2% of all pancreatitis cases [1.6.2]. The question of if and **can lamivudine cause pancreatitis** is a significant consideration for patients and clinicians, as it is a known, though rare, potential side effect [1.8.3].

According to the Centers for Disease Control and Prevention (CDC), modern antiretroviral therapy can suppress the HIV virus to undetectable levels. A key component in achieving this is understanding what class of drug is bictegravir emtricitabine, as this combination leverages two powerful mechanisms to fight HIV.

Abacavir is a nucleoside reverse transcriptase inhibitor (NRTI), a class of antiretroviral medications used to treat human immunodeficiency virus (HIV) infection. It is often prescribed as part of a combination therapy to reduce the amount of HIV in the body.

The abbreviation **ABC** is used in a clinical setting to refer to the antiretroviral medication **abacavir**, a cornerstone of combination therapies for HIV-1 infection. Knowing which drug is ABC is particularly crucial due to the risk of a serious, potentially fatal hypersensitivity reaction that can occur in some individuals.

Since its FDA approval in 2003, emtricitabine has become a fundamental component of modern HIV therapy, especially when combined with other medications. An individual may be prescribed emtricitabine for two primary reasons: to treat an existing HIV infection or to prevent a potential one in at-risk individuals.

Stavudine, an antiretroviral medication once commonly used for HIV/AIDS, is widely known by at least two other names: its brand name, Zerit, and its chemical shorthand, d4T. It was approved in the US in 1994 and became available as a generic medicine.

Approved by the FDA in 1987 as the first antiretroviral drug, Retrovir (zidovudine or AZT) revolutionized the treatment of HIV/AIDS. Its primary use today, in combination with other medications, is to manage HIV infection and prevent its transmission from mother to child.

Approved by the FDA in 1987, azidothymidine (AZT) was the very first antiretroviral medication for treating HIV. To understand how does AZT work, one must first grasp its role as a nucleoside analog that disrupts the virus's replication cycle by targeting a key viral enzyme.

First approved by the FDA in 1995 for HIV treatment, lamivudine is a foundational antiviral medication used to manage two major viral infections. This versatile drug, often referred to as 3TC, is a key component in treatment regimens for individuals infected with the human immunodeficiency virus (HIV) and chronic hepatitis B virus (HBV).